The Re-Prosper HF Study
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 125 participants.
Also called NCT04551222
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 125 participants
- Registry
-
NCT04551222
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT04551222. Randomized; quadruple masking; primary purpose treatment. Start 2021-06-09 (actual); primary completion 2025-12-31 (actual). Results posted on 2026-09-14.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Re-Prosper HF Study
- Acronym
- Re-Prosper HF
- Condition
- Heart Failure
- Intervention (Drug)
- probenecid
- Intervention (Drug)
- Placebo
- Lead sponsor
- VA Office of Research and Development
Record details
- Record id
cardio:ct-nct04551222- Content hash
7ee9b017bf6eada4ba655d1afa829377a15884149fe03a4ee217edbaffdc337b